Study to Compare the Effect of Treatment With Carbidopa/Levodopa/Entacapone on the Quality of Life of Patients With Parkinson's Disease. This Study is Not Recruiting in the United States
Study to Compare the Effect of Treatment With Carbidopa/Levodopa/Entacapone on the Quality of Life of Patients With Parkinson's Disease. This Study is Not Recruiting in the United States
This study examines the effect of treatment of levodopa/entacapone on quality of life, as
 measured by the Parkinson's Disease-Questionnaire 8 (PDQ-8), in Parkinson's disease patients
 with no or minimal, non-disabling motor fluctuations.
This study examines the effect of treatment of levodopa/entacapone on quality of life, as
 measured by the Parkinson's Disease-Questionnaire 8 (PDQ-8), in Parkinson's disease patients
 with no or minimal, non-disabling motor fluctuations. Treatment with
 carbidopa/levodopa/entacapone will be compared with treatment with standard formulation
 levodopa/carbidopa.
Inclusion Criteria:

 -  Clinical diagnosis of idiopathic Parkinson's disease exhibiting at least 2 or 3
 symptoms

 -  Motor functions must be regarded as non-disabling by the patient

 Exclusion Criteria:

 -  History, signs or symptoms suggesting the diagnosis of atypical or secondary
 parkinsonism

 -  History of dyskinesia

 -  Previous or current use of entacapone or tolcapone

 -  Unstable Parkinson's disease patients requiring/receiving regimens of levodopa

 -  Subjects taking levodopa/DDCI controlled release or extended release formulations